Aveo Capital Partners, LLC Eli Lilly & CO Transaction History

Aveo Capital Partners, LLC

$910 Million
Q3 2024

A detailed history of Aveo Capital Partners, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Aveo Capital Partners, LLC holds 1,617 shares of LLY stock, worth $1.22 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

1,617

Previous 1,667 3.0%

Holding current value

$1.22 Million

Previous $1.51 Million 5.1%

% of portfolio

0.16%

Previous 0.18%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$772.14 - $960.02 $38,607 - $48,001	-50 Reduced 3.0%	1,617 $1.43 Million
Q2 2024 Aug 02, 2024	SELL	$724.87 - $909.04 $245,730 - $308,164	-339 Reduced 16.9%	1,667 $1.51 Million
Q1 2024 May 06, 2024	SELL	$592.2 - $792.28 $8,290 - $11,091	-14 Reduced 0.69%	2,006 $1.56 Million
Q4 2023 Feb 06, 2024	BUY	$525.19 - $619.13 $80,354 - $94,726	153 Added 8.19%	2,020 $1.18 Million
Q3 2023 Nov 06, 2023	SELL	$434.7 - $599.3 $147,363 - $203,162	-339 Reduced 15.37%	1,867 $1 Million
Q2 2023 Aug 08, 2023	BUY	$350.74 - $468.98 $51,909 - $69,409	148 Added 7.19%	2,206 $1.03 Million
Q1 2023 May 03, 2023	SELL	$310.63 - $364.82 $28,267 - $33,198	-91 Reduced 4.23%	2,058 $706,000
Q4 2022 Feb 03, 2023	BUY	$321.55 - $374.67 $19,614 - $22,854	61 Added 2.92%	2,149 $786,000
Q3 2022 Nov 09, 2022	BUY	$296.48 - $337.87 $3,261 - $3,716	11 Added 0.53%	2,088 $675,000
Q2 2022 Aug 05, 2022	SELL	$278.73 - $327.27 $7,246 - $8,509	-26 Reduced 1.24%	2,077 $673,000
Q1 2022 May 13, 2022	BUY	$234.69 - $291.66 $2,346 - $2,916	10 Added 0.48%	2,103 $602,000
Q4 2021 Feb 11, 2022	SELL	$224.85 - $279.04 $6,070 - $7,534	-27 Reduced 1.27%	2,093 $578,000
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $7,091 - $8,726	-32 Reduced 1.49%	2,120 $490,000
Q2 2021 Aug 13, 2021	SELL	$180.55 - $233.54 $2,708 - $3,503	-15 Reduced 0.69%	2,152 $494,000
Q1 2021 May 11, 2021	BUY	$164.32 - $212.72 $356,081 - $460,964	2,167 New	2,167 $405,000
Q4 2020 Feb 10, 2021	SELL	$130.46 - $172.63 $293,535 - $388,417	-2,250 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$146.22 - $169.13 $328,995 - $380,542	2,250 New	2,250 $333,000
Q2 2020 Aug 12, 2020	SELL	$136.42 - $164.18 $292,893 - $352,494	-2,147 Closed	0 $0
Q1 2020 May 05, 2020	SELL	$119.05 - $147.35 $32,976 - $40,815	-277 Reduced 11.43%	2,147 $298,000
Q4 2019 Feb 06, 2020	BUY	$106.92 - $132.43 $4,704 - $5,826	44 Added 1.85%	2,424 $319,000
Q3 2019 Nov 07, 2019	SELL	$106.79 - $116.16 $1,708 - $1,858	-16 Reduced 0.67%	2,380 $269,000
Q2 2019 Aug 06, 2019	BUY	$110.79 - $129.32 $5,428 - $6,336	49 Added 2.09%	2,396 $260,000
Q1 2019 May 07, 2019	BUY	$111.31 - $131.02 $29,608 - $34,851	266 Added 12.78%	2,347 $305,000
Q4 2018 Feb 11, 2019	SELL	$105.9 - $118.64 $6,459 - $7,237	-61 Reduced 2.85%	2,081 $241,000
Q3 2018 Nov 09, 2018	BUY	$85.86 - $107.31 $183,912 - $229,858	2,142 New	2,142 $240,000

Others Institutions Holding LLY

# of Institutions

4,007

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $717B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aveo Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aveo Capital Partners, LLC with notifications on news.

Account

Aveo Capital Partners, LLC Eli Lilly & CO Transaction History